Leerink Partnrs Issues Pessimistic Forecast for TMO Earnings
Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) – Research analysts at Leerink Partnrs reduced their Q2 2025 earnings estimates for Thermo Fisher Scientific in a report issued on Wednesday, April 23rd. Leerink Partnrs analyst P. Souda now expects that the medical research company will post earnings of $5.23 per share for the quarter, down […]
